個(gè)人簡(jiǎn)介：

上海誠益生物科技有限公司創(chuàng )始人、首席執行官

前禮來(lái)（中國）研發(fā)中心化學(xué)部門(mén)負責人，帶領(lǐng)和指導項目團隊達成多項項目里程碑并順利完成臨床前藥物發(fā)現和開(kāi)發(fā)。

初創(chuàng )型生物醫藥企業(yè)Tetraphase Pharmaceutical和大型跨國藥企GSK和禮來(lái)中國研發(fā)中心等企業(yè)的任職過(guò)程中曾參與和領(lǐng)導多項小分子新藥研發(fā)項目

公司簡(jiǎn)介：

Eccogene is dedicated to innovative drug discovery for metabolic and immune related diseases. Metabolic system is responsible for converting nutrients to energy to sustain normal physiological process of human body. Dysregulation of metabolic pathways in metabolic organs leads to variety of metabolic diseases, such as diabetes, obesity and NASH. When it happened in immune cells, immune overactivation or suppression can be manifested as auto-immune diseases or tumorigenesis, respectively. Eccogene’s team has demonstrated experience in drug discovery, with deep scientific insight of metabolic pathways and technical know-how to solve complex problems. We have also enabled unique platforms to support novel drug discovery from target to market.